Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:810439.
doi: 10.1155/2015/810439. Epub 2015 Apr 28.

Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine

Affiliations
Review

Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine

S W Seto et al. Int J Endocrinol. 2015.

Abstract

Diabetes mellitus (DM) is a metabolic disorder affecting a large number of people worldwide. Numerous studies have demonstrated that DM can cause damage to multiple systems, leading to complications such as heart disease, cancer, and cerebrovascular disorders. Numerous epidemiological studies have shown that DM is closely associated with dementia and cognition dysfunction, with recent research focusing on the role of DM-mediated cerebrovascular damage in dementia. Despite the therapeutic benefits of antidiabetic agents for the treatment of DM-mediated cognitive dysfunction, most of these pharmaceutical agents are associated with various undesirable side-effects and their long-term benefits are therefore in doubt. Early evidence exists to support the use of traditional Chinese medicine (TCM) interventions, which tend to have minimal toxicity and side-effects. More importantly, these TCM interventions appear to offer significant effects in reducing DM-related complications beyond blood glucose control. However, more research is needed to further validate these claims and to explore their relevant mechanisms of action. The aims of this paper are (1) to provide an updated overview on the association between DM and cognitive dysfunction and (2) to review the scientific evidence underpinning the use of TCM interventions for the treatment and prevention of DM-induced cognitive dysfunction and dementia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanism of DM-mediated cognitive dysfunction.

Similar articles

Cited by

References

    1. Darsalia V., Heldmann U., Lindvall O., Kokaia Z. Stroke-induced neurogenesis in aged brain. Stroke. 2005;36(8):1790–1795. doi: 10.1161/01.STR.0000173151.36031.be. - DOI - PubMed
    1. Whiting D. R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 2011;94(3):311–321. doi: 10.1016/j.diabres.2011.10.029. - DOI - PubMed
    1. Arvanitakis Z., Wilson R. S., Bienias J. L., Evans D. A., Bennett D. A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of Neurology. 2004;61(5):661–666. doi: 10.1001/archneur.61.5.661. - DOI - PubMed
    1. Breteler M. M. B. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam study and the Rotterdam scan study. Annals of the New York Academy of Sciences. 2000;903:457–465. doi: 10.1111/j.1749-6632.2000.tb06399.x. - DOI - PubMed
    1. Strachan M. W. J., Reynolds R. M., Marioni R. E., Price J. F. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nature Reviews Endocrinology. 2011;7(2):108–114. doi: 10.1038/nrendo.2010.228. - DOI - PubMed

LinkOut - more resources